C4 Therapeutics, Inc. (CCCC)
2.93
-0.04
(-1.35%)
USD |
NASDAQ |
May 06, 16:00
2.92
-0.01
(-0.34%)
After-Hours: 20:00
C4 Therapeutics Total Assets (Quarterly) : 371.94M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 207.62B |
| Biogen, Inc. | 29.48B |
| Merck & Co., Inc. | 128.68B |
| Bristol Myers Squibb Co. | 86.48B |
| BrightSpring Health Services, Inc. | 6.213B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 115.35M |
| Shareholders Equity (Quarterly) | 256.59M |
| Debt to Equity Ratio | 0.2338 |
| Current Ratio | 7.814 |
| Net Debt Paydown Yield | 0.77% |